Nutrition 53, Inc. – Trademark Portfolio

Entity Type: 03

Nutrition 53, Inc. holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 16 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include N53, LEAN1, NEURO1, and SLEEP1. The owner is based in Lafayette, CA.

3706 Mt. Diablo Blvd Suite 300

Lafayette, CA 94549

17 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Nutrition 53, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (16 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

32
Light Beverages (1 filing)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

Frequently Asked Questions

How many trademarks does Nutrition 53, Inc. have?

Nutrition 53, Inc. has 17 U.S. trademarks filed with the USPTO. Of these, 4 registered, 10 abandoned, 3 cancelled.

What trademark classes does Nutrition 53, Inc. file in?

Nutrition 53, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 32 (Light Beverages). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Nutrition 53, Inc.'s most well-known trademarks?

Nutrition 53, Inc.'s registered trademark portfolio includes well-known marks such as N53, LEAN1, NEURO1, and SLEEP1. These are among 4 currently registered trademarks in the portfolio.

What is Nutrition 53, Inc.'s trademark registration success rate?

Nutrition 53, Inc. has a 24% trademark registration rate, with 4 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.